Inventor

SOMMADOSSI JEAN-PIERRE

US83 patents

⚠️ This page may combine multiple inventors who share the name “SOMMADOSSI JEAN-PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SOMMADOSSI JEAN-PIERRE

IDENIX PHARMACEUTICALS INC

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Methods and compositions for treating hepatitis C virus

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections

Methods and compositions for treating hepatitis C virus

Methods and compositions for treating flaviviruses and pestiviruses

Methods and compositions for treating flaviviruses and pestiviruses

Compounds and pharmaceutical compositions for the treatment of viral infections

2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides

Compounds and pharmaceutical compositions for the treatment of viral infections

2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

Methods of treating hepatitis delta virus infection with β-L-2&#39;-deoxy-nucleosides

2′-branched nucleosides and Flaviviridae mutation

Phenylindoles for the treatment of HIV

ATEA PHARMACEUTICALS INC

Highly active compounds against COVID-19

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

UNIV CAGLIARI

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Methods and compositions for treating hepatitis C virus

Methods and compositions for treating flaviviruses and pestiviruses

Methods and compositions for treating hepatitis C virus

Methods and compositions for treating flaviviruses and pestiviruses

Methods and compositions for treating flaviviruses and pestiviruses

Methods and compositions for treating flaviviruses and pestiviruses

UNIV EMORY

Nucleosides with anti-hepatitis B virus activity

Nucleosides with anti-hepatitis B virus activity

Nucleoside with anti-hepatitis B virus activity

β-L nucleosides for the treatment of HIV infection

Treating HBV with phospholipid prodrugs of β-L-2&#39;,3&#39;-dideoxyadenosine 5&#39;-monophosphate

SOMMADOSSI JEAN-PIERRE

Methods and compositions for treating hepatitis C virus

Compounds and pharmaceutical compositions for the treatment of viral infections

2′-branched nucleosides and Flaviviridae mutation

UAB RESEARCH FOUNDATION

Methods for increasing uridine levels with L-nucleosides

β-L-2&#39;-deoxy-nucleosides for the treatment of HIV infection

CENTRE NAT RECH SCIENT

Methods and compositions for treating hepatitis C virus using 4&#39;-modified nucleosides

SCHINAZI RAYMOND F

Method to improve the biological and antiviral activity of protease inhibitors

STORER RICHARD

Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections

UNIV GEORGIA

5&#39;-diphosphohexose nucleoside pharmaceutical compositions

Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides

Treating HBV with phospholipid prodrugs of β-L-2',3'-dideoxyadenosine 5'-monophosphate

β-L-2'-deoxy-nucleosides for the treatment of HIV infection

Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides

5'-diphosphohexose nucleoside pharmaceutical compositions